A Multicenter Assessment of ALD403 in Chronic Migraine

NCT02275117 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

665

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

BIOLOGICAL: ALD403
BIOLOGICAL: Placebo

Sponsor

Alder Biopharmaceuticals, Inc.